Autacoids and Related Drugs: Technologies and Global Markets

May 10, 2010

Wellesley, Mass. – According to a new technical market research report, AUTACOIDS AND RELATED DRUGS: TECHNOLOGIES AND GLOBAL MARKETS (PHM065A) from BCC Research (www.bccresearch.com), the value of the market for autacoids and related drugs is an estimated $96.2 billion in 2010, but is expected to increase to $112.6 billion in 2015, for a 5-year compound annual growth rate (CAGR) of 3.2%.

The largest segment of the market, biogenic amines, is projected to increase at a CAGR of 2.5% to $71.1 billion in 2015, after being valued at an estimated $62.9 billion in 2010.

Polypeptide autacoids, making up the second-largest segment, are estimated at $21.2 billion in 2010, and are expected to increase at a CAGR of 3.3% to reach $24.9 billion in 2015.

The lipid-derived autacoids segment is expected to have a 5-year CAGR of 2.7%, with values of $9.7 billion in 2010 and $11.1 billion in 2015.

The smallest segment of the market, made up of endothelium-derived autacoids, is projected to have the highest rate of growth by far, an 18% CAGR, rising from $2.4 billion in 2010 to $5.5 billion in 2015.

Autacoids, also called local hormones, are associated with a number of pathological conditions, such as allergies, hay fever, asthma, cardiovascular diseases and certain central nervous system (CNS) disorders. The number of people suffering from some kind of allergy is growing; subsequently, the demand for autacoids-related drugs for allergic rhinitis and other allergic conditions is on the rise worldwide.

The market for autacoids and related products is mature, with a number of high-profile patent losses anticipated in the near future, and a strong over-the-counter (OTC) segment, especially in the anti-allergy market.

The scope of this study encompasses the autacoid-related product manufacturers and various therapeutic medical markets. BCC analyzes each market and its applications by reviewing its regulatory environment, technology involved, market projections, and market share.  Technological issues include the latest trends and developments.

The report will be of interest to analytical companies, physicians, the pharmaceutical and biopharmaceutical industries, hospitals, and research institutes.

Autacoids and Related Drugs: Technologies and Global Markets( PHM065A )
Publish Date: Apr 2010    

Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email press@bccresearch.com or visit www.bccresearch.com/media to request access to our library of market research.